Current analytical strategies for C-reactive protein quantification in blood

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 1-9

  Algarra, Manuel ^a   Gomes, Diana ^a   Esteves da Silva, Joaquim C G ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Blood analysis; C reactive protein; Immunoassays; Nanoparticles

Indexed keywords

C REACTIVE PROTEIN; NANOPARTICLE; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; POLYAMIDOAMINE; POLYMER;

ANTIGEN BINDING; BLOOD ANALYSIS; CHEMOLUMINESCENCE; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; MOLECULAR IMPRINTING; NANOTECHNOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; REVIEW; SURFACE PLASMON RESONANCE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ETHANOLAMINES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMMUNOASSAY; INFLAMMATION; MOLECULAR IMPRINTING; PHOSPHORYLCHOLINE; PRIMARY PREVENTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE;

EID: 84866657780     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.007     Document Type: Review

References (81)

1. Adams J.E. Clinical integration of C-reactive protein for primary and secondary risk factor stratification. Markers in cardiology. A case oriented approach 2007, 201. Wiley-Blackwell, Massachusetts. J.A. Adams, F.S. Apple, A.S. Jaffe (Eds.).
2. Grundy S.M., Balady G.J., Criqui M.H., Fletcher G., Greenland P., Hiratzka L.F., Houston-Miller N., Kris-Etherton P., Krumholz H.M., LaRosa J., Ockene I.S., Pearson T.A., Reed J., Washington R., Smith S.C. Primary prevention of coronary heart disease: guidance from Framingham. Circulation 1998, 89:1876-1887.
3. Smith S.C., Greenland P., Grundy S.M. Prevention conference V: beyond secondary prevention: identifying the high-risk for primary prevention: executive summary. Circulation 2000, 101:111-116.
4. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003, 107:499-511.
5. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
6. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 2002, 347:1557-1565.
7. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001, 103:1813-1818.
8. Glynn R.J., Cook N.R. C-reactive protein and coronary heart disease. N. Engl. J. Med. 2004, 351:295-298.
9. Pepys M.B., Hirschfiel G.M. C-reactive protein: a critical update. J. Clin. Invest. 2003, 101:1805-1812.
10. Thompson D., Pepys M.B., Wood S.P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999, 7:169-177.
11. Patel D.N., King C.A., Bailey S.R., Holt J.W., Venkatachalam K., Agrawal A., Valente A.J., Chandrasekar B. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-κB and C/EBPβ activation. J. Biol. Chem. 2007, 282:27229.
12. Dong Q., Wright J.R. Expression of C-reactive protein by alveolar macrophages. J. Immunol. 1996, 156:4815-4820.
13. Oliveira E.B., Gotschlich E.C., Liu T.Y. Primary structure of human C-reactive protein. Proc. Natl. Acad. Sci. U.S.A. 1977, 74:3148-3151.
14. Ablij H.C., Meinders A.E. C-reactive protein: history and revival. Eur. J. Intern. Med. 2002, 13:412-422.
15. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease. Detection and prevention. Circulation 2003, 107:363-369.
16. Armani A., Becker R.C. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II. Am. Heart J. 2004, 149:295-298.
17. Mikkelsen S.R., Cortón E. Bioanalytical chemistry 2004, John Wiley & Sons, Inc. Hoboken, NJ.
18. Robey F.A., Liu T. Synthesis and use of new labelled derivatives of phosphorylcholine in a comparative study of human, dogfish, and limulus C-reactive proteins. J. Bio. Chem. 1983, 258:3895-3900.
19. Ledue T.B., Poulin S.E., Leavitt L.F., Johnson A.M. Evaluation of a particle-enhanced immunoassay for quantifying C-reactive protein. Clin. Chem. 1989, 35:2001-2002.
20. Merrit C.M., Winkelman J.W. Electrochemical method for measuring C-reactive protein using crown ether-phosphate ester ionophores. Anal. Chem. 1989, 61:2362-2365.
21. Urdal P., Borch S.M., Landaas S., Krutnes M.B., Gogstad G.O., Hjortdahl P. Rapid immunometric measurement of C-reactive protein in whole blood. Clin. Chem. 1992, 38:580-584.
22. Nilsson S., Lager C., Laurell T., Birnbaum S. Thin-layer immunoaffinity chromatography with bar code quantitation of C-reactive protein. Anal. Chem. 1995, 67:3051-3056.
23. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 1999, 45:2136-2141.
24. Roberts W.L., Moulton L., Law T.C., Farrow G., Cooper-Anderson M., Savory J., Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin. Chem. 2001, 47:418-425.
25. Wolf M., Juncker D., Michel B., Hunziker P., Delamarche E. Simultaneous detection of C-reactive protein and other cardiac markers in human plasma using micromosaic immunoassays and self-regulating microfluidic networks. Biosens. Bioelectron. 2004, 19:1193-1202.
26. Lee JH J.H., Yoon K.H., Wang K.S., Park J., Ahn S., Kim T.S. Label free novel electrical detection using micromachined PZT monolithic film cantilever for the detection of C-reactive protein. Biosens. Bioelectron 2004, 20:269-275.
27. Afara H.N., Omanovic S., Padjen A.L. Electrochemical investigations of the interaction of C-reactive protein (CRP) with a CRP antibody chemically immobilized on a gold surface. Anal. Chim. Acta 2009, 643:45-53.
28. Qureshi A., Gurbuz Y., Kallempudi S.S., Kolkar M., Niazi J.H. Label-free RNA aptamer-based capacitive biosensor for the detection of C-reactive protein. Phys. Chem. Chem. Phys. 2010, 12:9176-9182.
29. Kim N., Kim D.K., Cho Y.J. Development of indirect-competitive quartz crystal microbalance immunosensor for C-reactive protein. Sensor Act. B: Chem. 2009, 143:444-448.
30. Lee M., Lee D., Jung S., Lee K., Park Y.S., Seong W.K. Measurements of serum C-reactive protein levels in patients with gastric cancer and quantification using silicon nanowire arrays. Nanomed. 2010, 6:78-83.
31. Zhu X., Duana D., Publicover N.G. Magnetic bead based assay for C-reactive protein using quantum-dot fluorescence labeling and immunoaffinity separation. Analyst 2010, 135:381-389.
32. Cowles C.L., Zhu X. Sensitive detection of cardiac biomarker using ZnS nanoparticles as novel signal transducers. Biosens. Bioelectron. 2011, 30:342-346.
33. Zhou F., Lu M., Wang W., Bian Z.P., Zhang J.R., Zhu J.J. Electrochemical immunosensor for simultaneous detection of dual cardiac markers based on a poly(dimethylsiloxane)-gold nanoparticles composite microfluidic chip: a proof of principle. Clin. Chem. 2010, 56:1701-1707.
34. Albrecht C., Kaeppel N., Gauglitz G. Two immunoassay formats for fully automated CRP detection in human serum. Anal. Bioanal. Chem. 2008, 391:1845-1852.
35. Park J., Kurosawa S., Watanabe J., Ishihara K. Evaluation of 2 methacryloyloxyethyl phosphorylcholine polymeric nanoparticle for immunoassay of C-reactive protein detection. Anal. Chem. 2004, 76:2649-2655.
36. Koskinem J.O., Vaarno J., Meltola N.J., Soini J.T., Hanninen P.E., Luotola J., Waris M.E., Soini A.E. Fluorescent nanoparticles as labels for immunometric assay of C-reactive protein using two-photon excitation assay technology. Anal. Biochem. 2004, 328:210-218.
37. Kriz K., Ibraimi F., Lu M., Hansson L., Kriz D. Detection of C-reactive protein utilizing magnetic permeability detection based immunoassays. Anal. Chem. 2005, 77:5920-5924.
38. Kriz K., Ibraimi F., Lu M. Rapid one-step whole blood C-reactive protein magnetic permeability immunoassay with monoclonal antibody conjugated nanoparticles as superparamagnetic labels and enhanced sedimentation. Anal. Bioanal. Chem. 2006, 384:1618-2642.
39. Tsai H.Y., Hsu C.F., Chiu I.W., Fuh C.B. Detection of C-reactive protein based on immunoassay using antibody-conjugated magnetic nanoparticles. Anal. Chem. 2007, 79:8416-8419.
40. Colfen H., Volkel A., Eda S., Kobold U., Kaufmann J., Puhlmann A., Goltner C., Wachernig H. Mechanism of nanoparticle-enhanced turbidimetric assays applying nanoparticles of different size and immunoreactivity. Langmuir 2002, 18:7623-7628.
41. Mishra S.K., Pasricha R., Biradar, Rajesh A.M. ZnS-nanocrystals/polypyrrole nanocomposite film based immunosensor. Appl. Phys. Lett. 2012, 100:53701-53704.
42. Wang S., Harris E., Shi J., Chen A., Parajuli S., Jingab X., Miao W. Electrogenerated chemiluminescence determination of C-reactive protein with carboxyl CdSe/ZnS core/shell quantum dots. Phys. Chem. Chem. Phys. 2010, 12:10073-10080.
43. Härmä H., Toivonen J., Soini J.T., Hänninen P., Parak W.J. Time-resolved fluorescence immunoassay for C-reactive protein using colloidal semiconducting nanoparticles. Sens. 2011, 11:11335-11342.
44. Miao W., Bard A.J. Electrogenerated chemiluminescence. 72, determination of immobilized DNA and C-reactive protein on Au(111) electrodes using tris (2,2'-bipyridyl) ruthenium(II) labels. Anal. Chem. 2003, 75:5825-5834.
45. 2+ containing microspheres. Anal. Chem. 2004, 76:7109-7113.
46. 2+. Encapsulated liposomes as labels. Anal. Chem. 2007, 79:459-463.
47. Islam M.D., Lee H.G., Choo J., Song J.M., Kang S.H. High sensitive detection of C-reactive protein by total internal reflection fluorescence microscopy on rapidly making nanoarray protein chip. Talanta 2010, 81:1402-1408.
48. Gubala V., Crean C., Nooney R., Hearty S., McDonnell B., Heydon K., O'Kennedy R., MacCraith B.D., Williams D.E. Kinetics of immunoassays with particles as labels: effect of antibody coupling using dendrimers as linkers. Analyst 2011, 136:2533-2541.
49. Deegan O., Walshe K., Kavanagh K., Doyle S. Quantitative detection of C-reactive protein using phosphocholine-labelled enzyme or microspheres. Anal. Biochem. 2003, 312:175-181.
50. Tugirimana P.L., Holderbeke A.L., Kint J.A., Delanghe J.R. A new turbidimetric method for assaying serum C-reactive protein based on phosphocholine interaction. Clin. Chem. Lab. Med. 2009, 47:1417-1422.
51. Sreenivasan K., Raj V., Hari P.R. Use of chemically modified thermoresponsive copolymers for the detection of C-reactive protein. Anal. Chim. Acta 2007, 592:45-50.
52. Gomes D., Algarra M., Diez de los Rios M.J., Arrebola M.M., Herrera Gutiérrez M.E., Seller Pérez G., Esteves da Silva J.C.G. CdSe quantum dots capped PEA for screening C-reactive protein. Talanta 2012, 93:411-414.
53. Algarra M., Campos B.B., Gomes D., Alonso B., Casado C.M., Arrebola M.M., Díez de los Rios M.J., Herrera-Gutiérrez M.E., Seller-Pérez G., Esteves da Silva J.C.G. Talanta 2012, 99:574-579.
54. Islam M.D.S., Kang S.H. Chemiluminescence detection of label-free C-reactive protein based on catalytic activity of gold nanoparticles. Talanta 2011, 84:752-758.
55. Islam M.D., Yu H., Lee H.G., Kang S.H. Molecular switching fluorescence based high sensitive detection of label free C-reactive protein on biochip. Biosens. Bioelectron. 2010, 26:1028-1035.
56. Yang J., Joo K.W., Kim Y.S., Ann C., Han J.S., Kim S., Lee J.S. Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies. J. Nephrol. 2005, 18:102-105.
57. Burstein E., Chen W.P., Chen Y.J., Hartstein A. Surface polaritons propagating electromagnetic modes at interfaces. J. Vac. Sci. Technol. 1974, 11:1004-1019.
58. Wang T.J., Hsieh C.W. Phase interrogation of localized surface plasmon resonance biosensors based on electro-optic modulation. Appl. Phys. Lett. 2007, 91:113903.
59. Hu W.P., Hsu H.Y., Chiou A., Tseng K.Y., Lin H.Y., Changa G.L., Chend S.J. Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing. Biosens. Bioelectron. 2006, 21:1631-1637.
60. Kim H.C., Lee S.K., Sohn Y.S., Ryu H.K., Jeong S.W. Preparation of a sensing membrane for C-reactive protein. Macromol. Symp. 2007, 249-250:71-75.
61. Endo T., Kerman K., Nagatani N., Hiepa H.M., Kim D.K., Yonezawa Y., Nakano K., Tamiya E. Multiple label-free detection of antigen-antibody reaction using localized surface plasmon resonance-based core-shell structured nanoparticle layer nanochip. Anal. Chem. 2006, 78:6465-6475.
62. Jung S.H., Jung J.W., Suh I.B., Yuk J.S., Kim W.J., Choi E.Y., Kim Y.M., Ha K.S. Analysis of C-reactive protein on amide-linked N-hydroxysuccinimide-dextran arrays with a spectral surface plasmon resonance biosensor for serodiagnosis. Anal. Chem. 2007, 79:5703-5710.
63. Yuk J.S., Jung J.W., Hyun J., Kim MK Y., Ha S. Development of a scanning surface plasmon microscope based on white light for analysis of a wide range of protein arrays. Sens. Actuators, B 2008, 131:241-246.
64. 2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor. Anal. Biochem. 2009, 391:39-44.
65. Okemefuma A.I., Stasch L., Rana S., Buetas A.J.Z., Gor J., Perkins S.J. C-reactive protein exists in an NaCl concentration-dependent pentamer-decamer equilibrium in physiological buffer. J. Biol. Chem. 2010, 285:1041-1052.
66. Yuk J.S., Hong D.G., Jung H.I., Ha K.S. Application of spectral SPR imaging for the surface analysis of C-reactive protein binding. Sens. Actuators, B 2006, 119:673-675.
67. Wulff G. Molecular imprinting in cross-linked materials with the aid of molecular templates, a way towards artificial antibodies. Angew. Chem. Int. Ed. Eng. 1995, 34:1812-1832.
68. Haupt K., Mosbach K. Molecularly imprinted polymers and their use in biomimetic sensors. Chem. Rev. 2000, 100:2495-2504.
69. Alexander C., Andersson H.S., Andersson L.I., Ansell R.J., Kirsch N., Nicholls I.A., O'Mahony J., Whitcombe M.J. Molecular imprinting science and technology: a survey of the literature for the years up to and including 2003. J. Mol. Recognit. 2006, 19:106-180.
70. Oliveira H.M., Segundo M.A., Lima J.L.F.C., Miró M., Cerda V. Exploiting automatic on-line renewable molecularly imprinted solid-phase extraction in lab-on-valve format as front end to liquid chromatography: application to the determination of riboflavin in foodstuffs. Anal. Bioanal. Chem. 2010, 397:77-86.
71. Liu X., Liu J., Huang Y., Zhao R., Liu G. Determination of methotrexate in human serum by high-performance liquid chromatography combined with pseudo template molecularly imprinted polymer. J. Chromatogr. A 2009, 44:7533-7538.
72. Beltran A., Marce R., Cormack P.A.G., Borrull F. Synthetic approaches to parabens molecularly imprinted polymers and their applications to the solid-phase extraction of river water samples. Anal. Chim. Acta 2010, 677:72-78.
73. Sergeyeya T.A., Slinchenko O.A., Gorgbach L.A., Matyushov V.F., Brovko O.O., Piletsky S.A., Sergeeva L.M., Elska G.V. Catalytic molecularly imprinted polymer membranes: development of the biomimetic sensor for phenols detection. Anal. Chim. Acta 2010, 659:274-279.
74. Mohajeri S.A., Karimi G., Khansari M.R. Clozapine imprinted polymers: synthesis, characterization and application for drug assay in human serum. Anal. Chim. Acta 2010, 683:143-148.
75. Prasad B.B., Madhuri R., Tiwari M.P., Sharma P.S. Enantioselective recognition of d- and l-tryptophan by imprinted polymer-carbon composite fiber sensor. Talanta 2010, 81:187-196.
76. Azodi-Deilami S., Abdouss S., Hasani S.A. Preparation and utilization of a molecularly imprinted polymer for solid phase extraction of tramadol. Cent. Eur. J. Chem. 2010, 8:861-869.
77. Chou P.C., Rick J., Chou T.C. C-reactive protein thin-film molecularly imprinted polymers formed using a micro-contact approach. Anal. Chim. Acta 2005, 542:20-25.
78. Chou T.C., Rick J., Weng Y.C. Nanocavity protein biosensor-fabricated by molecular imprinting, Proceedings of the 7th IEEE International Conference on Nanotechnology August 2-5 2007, 16-20. Hong Kong.
79. Clyne B., Olshaker J.S. The C-reactive protein. J. Emerg. Med. 1999, 17:1019-1025.
80. McCormack J.P., Allan G.M. Measuring hsCRP-an important part of a comprehensive risk profile or a clinically redundant practice?. PLoS Med. 2010, 7:e1000196.
81. U.S.Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of In Vitro Diagnostic Device Evaluation and Safety Division of Chemistry and Toxicology Devices Guidance for industry-review criteria for assessment of C-reactive protein (CRP), high sensitivity C-reactive protein (hsCRP) and cardiac C-reactive protein (cCRP) assays 2005.